Doctor profile · Federal record
Dr. Natalie Wallace, MD, MPH
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Anchorage, AK
- NPI 1386059061
- Accepts Medicare
- MIPS 60.1 / 100 · 2023
- 12 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2925 Debarr RD Ste 300
Anchorage, AK 995082974
(907) 279-3155
fax (907) 279-3154
Credentials & registration
- NPI registered
- June 2014 — 12 yrs on file
- Profile last updated
- November 24, 2021
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Alaska #159302
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1386059061. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
37,220
Distinct HCPCS
10
Medicare allowed
$1,549,295
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 19,000 | 27 | $54 | |
J0897 |
Injection, denosumab, 1 mg | 5,520 | 21 | $24 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,680 | 28 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,934 | 46 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,790 | 47 | $1 | |
J9312 |
Injection, rituximab, 10 mg | 1,180 | 13 | $80 | |
Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 408 | 17 | $136 | |
J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 334 | 13 | $4 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 314 | 104 | $148 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 266 | 112 | $229 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 1,428. This provider delivers 26× the peer median.Open Payments
Industry payments received
All-time total
$2,002
Transactions
63
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $237.01 | |
| Novartis Pharmaceuticals Corporation | 14 | $218.48 | |
| Janssen Biotech, Inc. | 4 | $152.97 | |
| ABBVIE INC. | 5 | $126.08 | |
| E.R. Squibb & Sons, L.L.C. | 6 | $125.02 | |
| SOBI, INC | 3 | $106.13 | |
| Celgene Corporation | 3 | $73.34 | |
| Merck Sharp & Dohme LLC | 3 | $70.45 | |
| Tempus AI, Inc | 3 | $68.76 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $60.49 | |
| Genentech USA, Inc. | 2 | $56.07 | |
| PUMA BIOTECHNOLOGY, INC. | 2 | $51.22 | |
| Mirati Therapeutics, Inc. | 2 | $50.76 | |
| ARRAY BIOPHARMA INC | 2 | $47.09 | |
| GlaxoSmithKline, LLC. | 2 | $44.93 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
207
Patients
46
Total drug cost
$701,373
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 63 | 16 | $1,492 |
| Eliquis (Apixaban) | Brand | 27 | 0 | $30,493 |
| Ondansetron Odt (Ondansetron) | Brand | 21 | 17 | $442 |
| Hydroxyurea | Generic | 20 | 0 | $325 |
| Lidocaine-Prilocaine (Lidocaine/Prilocaine) | Brand | 15 | 13 | $383 |
| Gabapentin | Generic | 14 | 0 | $71 |
| Lynparza (Olaparib) | Brand | 12 | 0 | $190,503 |
| Tabrecta (Capmatinib Hydrochloride) | Brand | 12 | 0 | $269,784 |
| Tagrisso (Osimertinib Mesylate) | Brand | 12 | 0 | $207,443 |
| Mirtazapine | Generic | 11 | 0 | $437 |
Hospital affiliations
Frequently asked questions
What is Dr. Natalie Wallace's medical specialty?
Dr. Natalie Wallace practices Hematology & Oncology Physician in Anchorage, AK.
Where does Dr. Natalie Wallace practice?
Dr. Natalie Wallace practices at 2925 Debarr RD Ste 300, Anchorage, AK 995082974. Office phone: 9072793155.
What is Dr. Natalie Wallace's NPI?
Dr. Natalie Wallace's National Provider Identifier (NPI) is 1386059061, issued by NPPES.
Does Dr. Natalie Wallace accept Medicare assignment?
Yes. Dr. Natalie Wallace accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Natalie Wallace commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, denosumab, 1 mg (HCPCS J0897); Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS Q9967). Source: CMS Medicare Physician & Other Practitioners file.